Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1402238-32-7

Post Buying Request

1402238-32-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1402238-32-7 Usage

General Description

4-(2-Fluorophenoxy)phenylboronic acid is a chemical compound with the formula C12H10BFO3. It is a boronic acid derivative with a fluorophenoxyphenyl group attached. 4-(2-Fluorophenoxy)phenylboronic acid is commonly used in organic synthesis, particularly in the formation of carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions. It is also used in the development of pharmaceuticals and agrochemicals due to its ability to modulate biological processes and enzyme functions. Additionally, 4-(2-Fluorophenoxy)phenylboronic acid has potential applications in the field of materials science and catalysis.

Check Digit Verification of cas no

The CAS Registry Mumber 1402238-32-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,2,2,3 and 8 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1402238-32:
(9*1)+(8*4)+(7*0)+(6*2)+(5*2)+(4*3)+(3*8)+(2*3)+(1*2)=107
107 % 10 = 7
So 1402238-32-7 is a valid CAS Registry Number.

1402238-32-7Relevant articles and documents

CYCLIC MOLECULES AS BRUTON'S TYROSINE KINASE INHIBITOR

-

, (2021/11/26)

The present invention relates to a novel molecule with protein tyrosine kinase inhibitory activity, and the synthesis and usage thereof. Specifically, the present invention relates to compound by formula A, pharmaceutically acceptable salts, hydrates or solvates thereof, and the synthesis and usage thereof.

TREATMENT OF DRY EYE

-

, (2014/02/16)

The present disclosure provides a method of treating dry eye by inhibition of Bruton's tyrosine kinase (hereinafter "BTK") inhibitors, pharmaceutical formulations comprising the same, and processes for preparing such compounds.

TYROSINE KINASE INHIBITORS

-

, (2012/12/13)

The present disclosure provides compounds and pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BLK, BMX, EGFR, HER2, HER4, ITK, TEC, BTK, and TXK and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1402238-32-7